4.7 Article

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents

期刊

CLINICAL CANCER RESEARCH
卷 28, 期 20, 页码 4509-4520

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-22-0632

关键词

-

类别

资金

  1. Bristol-Myers Squibb
  2. Asociacion Espanola para el Estudio del Higado (AEEH)
  3. German Research Foundation (DFG)
  4. Instituto de Salud Carlos III (ISCIII)
  5. European Social Fund
  6. European Social Fund (ESF)
  7. US Department of Defense
  8. Tisch Cancer Institute (Cancer Center)
  9. European Regional Development Fund (ERDF)
  10. Inserm
  11. Labex OncoImmunology Investissement d'Avenir
  12. Equipe labellisee par la Ligue Nationale Contre le Cancer
  13. Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement
  14. CERCA Programme/Generalitat de Catalunya
  15. Gilead Sciences Research Scholar Program in Liver Disease [HA 8754/1-1]
  16. Samuel Waxman Cancer Research Foundation [IFI18/00006]
  17. Spanish National Health Institute (MICINN)
  18. NIH [BES-2017-081286]
  19. Cancer Research UK [CA150272P3]
  20. Fondazione AIRC [P30 CA196521]
  21. Fundacion Cientifica de la Asociacion Espanola Contra el Cancer [PI16/00111, PI19/00036, PI18/00079]
  22. Generalitat de Catalunya (AGAUR)
  23. [2017_SGR_1753]
  24. [PID2019-105378RB-I00]
  25. [R01 DK128289-01]
  26. [C9380/A26813]
  27. [SGR-1358]

向作者/读者索取更多资源

This study investigated the molecular characteristics of HCC in Mongolia and compared them with Western HCC. Mongolian HCC patients were younger, with higher female prevalence and predominantly associated with HBV-HDV coinfection. Mongolian HCCs had significantly higher rates of protein-coding mutations and specific driver HCC genes. Unique mutational signatures and transcriptomic profiles were identified in Mongolian HCC, suggesting the involvement of genotoxic environmental factors.
Purpose: Mongolia has the world's highest incidence of hepa-tocellular carcinoma (HCC), with -100 cases/100,000 inhabi-tants, although the reasons for this have not been thoroughly delineated. ExperimentalDesign: We performed a molecular characteriza-tion of Mongolian (n = 192) compared with Western (n = 187) HCCs by RNA sequencing and whole-exome sequencing to unveil distinct genomic and transcriptomic features associated with envi-ronmental factors in this population.Results: Mongolian patients were younger, with higher female prevalence, and with predominantly HBV-HDV coinfection etiol-ogy. Mongolian HCCs presented significantly higher rates of pro-tein-coding mutations (121 vs. 70 mutations per tumor in Western), and in specific driver HCC genes (i.e., APOB and TSC2). Four mutational signatures characterized Mongolian samples, one of which was novel (SBS Mongolia) and present in 25% of Mongolian HCC cases. This signature showed a distinct substitution profile with a high proportion of T>G substitutions and was significantly associated with a signature of exposure to the environmental agent dimethyl sulfate (71%), a 2A carcinogenic associated with coal combustion. Transcriptomic-based analysis delineated three molecular clusters, two not present in Western HCC; one with a highly inflamed profile and the other significantly associated with younger female patients. Conclusions: Mongolian HCC has unique molecular traits with a high mutational burden and a novel mutational signature associated with genotoxic environmental factors present in this country.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据